Hiv protease inhibitors useful for the treatment of aids

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 307/20 (2006.01) A61K 31/335 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) C07D 309/10 (2006.01) C07D 309/12 (2006.01) C07D 333/32 (2006.01) C07D 333/48 (2006.01) C07D 335/02 (2006.01) C07D 405/12 (2006.01) C07D 407/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 453/02 (2006.01)

Patent

CA 2075666

95/RDM55 98/RDM56 18414 TITLE OF THE, INVENTION HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS ABSTRACT OF THE DISCLOSURE Compounds of the form, A-G-J wherein A is an amine protecting group or urethane, G a dipeptide isostere and J a small terminal group are described. They are distinguished by tetrahydrofuryl or tetrahydropyranyl substituents, and the like. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically 95/RDM55 98/RDM56 - ii - 414 acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hiv protease inhibitors useful for the treatment of aids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv protease inhibitors useful for the treatment of aids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv protease inhibitors useful for the treatment of aids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1394336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.